Keyphrases
High Risk
100%
Graft-versus-host Disease (GvHD)
100%
Disease-specific Mortality
100%
Allogeneic
100%
Stem Cell Transplant Recipients
100%
Transplant-related Mortality
100%
Peripheral Blood Stem Cell Transplantation
100%
Allogeneic Peripheral Blood Stem Cell Transplantation
33%
Transplantation
22%
Confidence Interval
11%
Performance Status
11%
Hematological Malignancies
11%
Immunosuppression
11%
Consecutive Patients
11%
Granulocyte Colony-stimulating Factor (G-CSF)
11%
Survivors
11%
Corticosteroids
11%
Cyclosporine
11%
Effective Strategies
11%
Extensive Disease
11%
Day Range
11%
High-dose Therapy
11%
Long-term Survivors
11%
Progression-free
11%
Graft-versus-host Disease Prophylaxis
11%
HLA-identical Sibling
11%
First Remission
11%
First Relapse
11%
Medicine and Dentistry
Graft Versus Host Reaction
100%
Stem Cell Transplant
100%
Peripheral Blood Stem Cell
100%
Chronic Graft Versus Host Disease
80%
Allogeneic Peripheral Blood Stem Cell Transplantation
60%
Hematologic Malignancy
20%
Progression Free Survival
20%
Immunosuppressive Treatment
20%
Drug Megadose
20%
Cyclosporine
20%
Granulocyte Colony Stimulating Factor
20%
Acute Graft Versus Host Disease
20%
Diseases
20%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Stem Cell Transplant
100%
Peripheral Blood Stem Cell
100%
Chronic Graft Versus Host Disease
80%
Allogeneic Peripheral Blood Stem Cell Transplantation
60%
Drug Megadose
20%
Immunosuppression
20%
Granulocyte Colony-Stimulating Factor
20%
Acute Graft Versus Host Disease
20%
Ciclosporin
20%
Progression Free Survival
20%